apl. Prof. Dr. Ramona Erber

Institute of Pathology

Is ovarian tissue transport at supra-zero temperatures compared to body temperature optimal for follicle survival? (2020) Raffel N, Dittrich R, Orlowski P, Tischer H, Sӧder S, Erber R, Hoffmann I, et al. Journal article BAP1 Loss is a Useful Adjunct to Distinguish Malignant Mesothelioma Including the Adenomatoid-like Variant From Benign Adenomatoid Tumors (2020) Erber R, Warth A, Muley T, Hartmann A, Herpel E, Agaimy A Journal article Un- and dedifferentiated endometrial carcinoma A rare entity with a wide range of differential diagnosis (2019) Hoehn AK, Brambs CE, Opitz S, Erber R, Hartmann A, Horn LC Journal article Frequency of GNAS mutation in intramuscular myxoma (2019) Erber R, Stöhr R, Haller F, Hartmann A, Agaimy A Conference contribution Immunohistochemical TP53 expression in atypical fibroxanthoma and their mimics (2019) Erber R, Hartmann A, Agaimy A Conference contribution Nuclear NR4A3 Immunostaining Is a Specific and Sensitive Novel Marker for Acinic Cell Carcinoma of the Salivary Glands (2019) Haller F, Skálová A, Ihrler S, Märkl B, Bieg M, Moskalev E, Erber R, et al. Journal article Tumor budding: A predictor for metastasis in the CAM xenograft model (2019) Muenzner JK, Ranjan RA, Eckstein M, Erber R, Kunze P, Geppert CI, Rübner M, et al. Conference contribution Prognostic effect of Ki-67 in common clinical subgroups of patients with HER2-negative, hormone receptor-positive early breast cancer (2019) Fasching P, Gaß P, Häberle L, Volz B, Hein A, Hack C, Lux MP, et al. Journal article A prediction model for pathological complete response after neoadjuvant chemotherapy of HER2-negative breast cancer patients (2018) Häberle L, Erber R, Gaß P, Hein A, Jud S, Langemann H, Rauh C, et al. Conference contribution TILGen study-immunological targets in patients with breast cancer : Influence of tumor-infiltrating lymphocytes (2018) Erber R, Hartmann A, Beckmann M, Mackensen A, Kremer A, Reimann H, Hübner H, et al. Journal article